Abstract
Risk factor for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic oncology research investigators coLLborAtion study (GORILLA-3004) (1152)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
